Qt Interval Prolongation clinical trials

Explore recruiting qt interval prolongation clinical trials.

Recruiting qt interval prolongation studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Qt Interval Prolongation trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Study is designed to assess the safety and tolerability of ceralasertib at increasing doses in combination with other anti-cancer treatment in patients with advanced tumours

France

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Qt Interval Prolongation trials by city

Qt Interval Prolongation in Toronto Qt Interval Prolongation in Vancouver Qt Interval Prolongation in Montreal Qt Interval Prolongation in Calgary Qt Interval Prolongation in Edmonton Qt Interval Prolongation in Ottawa Qt Interval Prolongation in Winnipeg Qt Interval Prolongation in Quebec City Qt Interval Prolongation in Hamilton Qt Interval Prolongation in Kitchener Qt Interval Prolongation in London Qt Interval Prolongation in Halifax Qt Interval Prolongation in New York Qt Interval Prolongation in Los Angeles Qt Interval Prolongation in Chicago Qt Interval Prolongation in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease